Answer
Migard (frovatriptan) is not recommended during breastfeeding unless clearly needed, because a risk to the infant cannot be excluded; if used, a 24-hour interval must be observed.
Sources for this answer
- MigardA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked